EB
Emily Bodnar HC Wainwright & Co Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
136
Avg Return
Past Year
Past Year
9.5%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
92.9%
Neutral
7.1%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
Medical Devices
Medical Instruments & Supplies
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Buy
Reiterated
| $28 |
243%
upside
| 1 | +1.2% |
0
%
| 20 Oct ‘25 yesterday |
|
|
|
Buy
Initiated
| $12 |
469%
upside
| 1 | +24% |
0
%
| 14 Oct ‘25 7 days ago |
|
|
|
Buy
Assumed
| $60 |
71%
upside
| 1 | -4.3% |
0
%
| 6 Oct ‘25 15 days ago |
|
|
|
Buy
Maintained
| $59 |
70%
upside
| 1 | +14% |
0
%
| 30 Sep ‘25 21 days ago |
|
|
|
Neutral
Downgraded
| – | – | 1 | +11% |
0
%
| 29 Sep ‘25 22 days ago |
|
|
|
Buy
Reiterated
| $23 |
444%
upside
| 2 | -5.1% |
0
%
| 10 Sep ‘25 1 month ago |
|
|
|
Buy
Reiterated
| $56 |
30%
upside
| 1 | +10% |
0
%
| 4 Sep ‘25 1 month ago |
|
|
|
Buy
Maintained
| $40 |
174%
upside
| 1 | -20% |
0
%
| 27 Aug ‘25 1 month ago |
|
|
|
Buy
Upgraded
| $35 |
138%
upside
| 1 | +98% |
0
%
| 15 Aug ‘25 2 months ago |
|
|
|
Buy
Reiterated
| $36 |
73%
upside
| 1 | +16% |
0
%
| 13 Aug ‘25 2 months ago |
|
|
|
Buy
Maintained
| $4 |
213%
upside
| 1 | +37% |
0
%
| 7 Aug ‘25 2 months ago |
|
|
|
Buy
Maintained
| $9 |
217%
upside
| 1 | +24% |
0
%
| 22 Jul ‘25 3 months ago |
|